We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Clinical Trials for New Drugs Should Enroll Older Patients
Clinical Trials for New Drugs Should Enroll Older Patients
November 11, 2009
Sponsors should include at least 100 geriatric patients in trials of new drugs to detect clinically important differences between patient populations, according to an International Conference on Harmonisation (ICH) question-and-answer (Q&A) document.